DAFTAR PUSTAKA

1. McPhee SJ and, Ganong WF. Patofisiologi penyakit, Edisi 5. Jakarta; EGC. 2010.

2. Howard IM. The prevention of foot ulceration in diabetic patients. Phys Med

Rehabil Clin N Am 2009;20(4):9-609.

3. Khallaf A-N, Fathi O, Ayad W, Fawzy A. Diabetic foot ulcers: concervative management as limb salvage. Egypt, J. Plast. Reconstr. Surgery 2006;30(2):107-111.

4. Frykberg RG, Zgonis T, Amstrong DG, et al. Diabetic foot disorders. A Clinical Practice Guideline (2006 revision). J Foot Ankle Surg 2006;45(5 Suppl):S1-66.

5. International Diabetes Federation. The global burden. Dalam: Nigel U, Eds. Diabetes atlas. 5th ed. Brussels: IDF; 2012.

6. Reiber GE and Ledoux WR. Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. In: Williams R, Editors. The Evidence Base for Diabetes Care. Washington: John Wiley & Sons; 2003.

7. Reilly M, Mohler E. Cilostazol: treatment of intermittent claudication. Ann Pharmacother 2001;35:48-56.

8. Nakamura N, Hamazaki T, Johkaji H, et al. Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with weripheral vascular disease. Clin Exp Med 2003;2(4):180-4.

9. Ahn CW, Lee HC, Park SW, et al. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001;52(1):45-53.

10. Miller MS. Pharmacotherapy as adjunctive treatment for serious foot wounds in the patient with diabetes: a case study. Ostomy Wound Manage 2003;49(4):52-5.

11. Mahameed AA. Peripheral arterial disease. Cleveland Clinic publications: Disease Management Project 2009; (online), (http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/peripheral-arterial-disease/, diakses 21 Juni 2013).

12. Layton M, Goodfield MJD, Ibbotson S, et al. Randomised trial of oral aspirin for chronic venous leg ulcers. TheLancet.com 1994; (online), 344: 164-165, (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(94)92759-6/abstract, diakses 21 Juni 2013).

13. Abougalambou SSI, Hassali MA, Sulaiman SAS, et al. Prevalence of vascular complications among type 2 diabetes mellitus outpatients at teaching hospital in Malaysia. J DiabeteMetab 2011; 2(1): 1-4.

14. Akhter JM, Khan IA, Shahpurkar VV, et al. Evaluation of the diabetic foot according to Wagner's classification in a rural teaching hospital. The British Journal of Diabetes and Vascular Disease 2011; 11: 74-79.

15. Steeper R. A Critical Review of the Aetiology of Diabetic neuropathic ulcers. J Wound Care 2005;14(3): 101-3.

16. Omi H, Okayama N, Shimizu M, Fuktomi T, Nakamura A, Imaeda K, et al. Cilostazol inhibist high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production. Microvas Res 2004;68(2):119-25.

17. Ohba R, Otaka M, Odashima M, Jin M, Komatsu K, Konishi N, et al. Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats. J Gastroenterol 2006;41(1): 34-40.

18. Kumar V, Cotran RS, Robbins SL. Buku ajar patologi. Edisi 7 Volume 1. Jakarta, EGC: 2011.

19. Mackay D, Miller AL. Nutritional support for wound healing. Alternative Medicine Review 2003;4(8): 359-377.

20. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Frontiers in Bioscience 2004;9: 283-289.

21. Thompson PD, Zimet R, Forbes WP, et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. American Journal of Cardiology 2002; 90(12): 1314-1319.

22. Katzung, B.G. Basic and clinical pharmacology. 9th edition. USA : Mc Graw Hill;2005.

23. Keast DH, Bowering CK, Evans AW, et al. Measure: a proposed assessment. Wound Repair Regen 2004;1293:S1-17.

24. Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res 2010; 89(3): 219-229.

25. Rathur H, Rajbhandari. Review prevention of diabetic foot ulcers: holy grail of out clinics. Int J Diabetes & Metabolism 2003; 11: 56-61.

26. Greenhagen RM, Johnson AR, Bevilacque NJ. Smoking cessation: the role of the foot and ankle surgeon. Foot ankle Spec 2010; 3(1): 21-8.

27. Herman H. Efektivitas Cilostazol dan plasebo sebagai ajuvan kaki diabetik Wagner II dan III di RSUD Hasan Sadikin. Tesis. Bandung: Fakultas Kedokteran Universitas Padjajaran Bandung, 2012.

28. Hutagalung HS. Efek aspirin, cilostazol serta clopidogrel terhadap outcome fungsional pada pasien stroke iskemik. Tesis. Medan: Fakultas Kedokteran Universitas Sumatera Utara, 2011.